Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add filters








Language
Year range
2.
Egyptian Journal of Pharmaceutical Sciences. 1997; 38 (1-3): 137-145
in English | IMEMR | ID: emr-44536

ABSTRACT

N,N'-bis [N-[4-hydroxymethylthioxanthen-9-on-1-yl] piperazine and its N-methylcarbamate derivative have been synthesized. The compounds are considered a combination of two molecules of the antischistosomal drug, hycanthone. The two compounds are possibly active as antitumor as well as antischistosomal


Subject(s)
Piperazines/chemistry , Piperazines/chemical synthesis , Piperazines/analogs & derivatives
3.
Egyptian Journal of Chemistry. 1995; 38 (4): 443-449
in English | IMEMR | ID: emr-37113

ABSTRACT

Xanthotoxin [8-methoxy psoralene] [1], a drug currently used for the treatment of leukodermia, has been the subject of several workers for more than 9decades due to its pharmacological and chemical interest [1-5] It has been previously shown that when 4-hydroxymethylxanthotoxin was subjected to methylation by dimethyl sulphate in alkaline medium gave the cyclized product 6 7-dimethoxy-4-hydroxymethyl-5-benzofurylpropenoic acid lactone [4][6]. Similar structure analogue in which the lactone oxygen [1'], is substituted by sulfer, was obtained by cleavage methylation of the corresponding 4-thioguanidinyl methyl derivative [7]. Structure elucidation of both cyclized products was based on their 1H NMR spectra


Subject(s)
Methoxsalen/chemistry
4.
5.
Egyptian Journal of Schistosomiasis and Infectious and Endemic Diseases. 1988; 10 (2): 269-74
in English | IMEMR | ID: emr-10213

Subject(s)
Schistosomicides
6.
Egyptian Journal of Chemistry. 1985; 28 (2): 149-51
in English | IMEMR | ID: emr-5607

ABSTRACT

In a previous communication we have reported the synthesis of some alpha trimethylsiloxy - w-methyl [ethoxy] silyl Substituted alkanes I as well as their conversion into 1-oxa-2,2 disubstituted-2-silacycloalkanes II


Subject(s)
Spectrum Analysis
SELECTION OF CITATIONS
SEARCH DETAIL